DATED January 1, 2022 Agreement for novation of contract among Continuing Parties and Outgoing Party and Incoming PartyPepGen Inc. • August 8th, 2023 • Pharmaceutical preparations
AMENDMENT NO. 1 TO LICENCE OF TECHNOLOGY AGREEMENTLicence of Technology Agreement • August 8th, 2023 • PepGen Inc. • Pharmaceutical preparations
This Amendment No. 1 to the Agreement (this “Amendment”), effective as of 12th February 2021 (the “Amendment Effective Date”), is made by and between Oxford University Innovation Limited (Company Registration No. 2199542) whose registered office is a University Offices, Wellington Square, Oxford OX1 2JD, England (“OUI”); Medical Research Council, as part of United Kingdom Research and Innovation (also known as UK Research and Innovation) a body corporate established pursuant to section 91 of the Higher Education and Research Act 2017 whose address is Polaris House, North Star Avenue, Swindon SN2 1FL, United Kingdom (“MRC”); and PepGen Limited (Company Registration No. 11170794) whose registered office is at Bioescalator, Innovation Building, The Old Road Campus, Roosevelt Drive, Headington, Oxford OX3 7FZ (the “Licensee”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Agreement.
